Clinical Trials
We are always on the lookout for participants for our clinical trials, in the areas of Type 2 Diabetes, Insomnia, Obesity and Anxiety. Please click on the relative links below to apply and find out more information.
Adults with Type 2 Diabetes
Electrical vestibular nerve stimulation (VeNS) compared to sham control as a means of improving glycemic control in adults with Type 2 Diabetes mellitus. In a 16-week study with type 2 diabetic patients, our Vestal DM technology demonstrated a 0.4% reduction in HbA1c.
Primary Outcomes: HbA1c reduction
Location: South Florida Research Organisation, Miami, Florida
Dates: 2022 – 2023
Apply NowPrimary Outcomes: HbA1c reduction
Location: New Med Research Miami, Florida
Dates: 2022 – 2023
Apply NowPrimary Outcomes: HbA1c reduction
Location: Palm Research Center, Las Vegas, Nevada
Dates: 2022 – 2023
Apply NowPrimary Outcomes: HbA1c reduction
Location: University College Dublin, Ireland
Dates: 2021 – 2023
Apply NowPrimary Outcomes: HbA1c reduction
Location: Nothern California Medical Research Centre
Dates: 2021 – 2023
Apply NowPrimary Outcomes: HbA1c reduction
Location: Oviedo Medical Research, Orlando Florida
Dates: 2021 – 2023
Apply NowPrimary Outcomes: HbA1c reduction
Location: Charlottesville Medical Research, Virginia
Dates: 2021 – 2023
Apply NowPrimary Outcomes: HbA1c reduction
Locations: The Exercise and Physical Activity Resource Center (EPARC), San Diego
Dates: 2021 – 2023
Apply NowType 2 Diabetes Weight Loss
Weight management study for individuals with Type 2 Diabetes taking insulin. In a 12-week study with overweight patients, our Vestal technology demonstrated a 2.1kg reduction in body weight (i.e., 2% reduction in body weight).
Primary Outcomes: Weight loss & reduced HbA1c
Locations: Belfast, Northern Ireland
Dates: 2022
Apply NowAnxiety
Anxiety is known to be one of the most common health concerns and is known to have detrimental effects on an individual’s mental and physical health. The Modius Stress device is indicated to manage anxiety through the action of Cranial Electrotherapy Stimulation being delivered to the head in a non-invasive way that has been shown to be both safe and effective across multiple populations.
We are actively recruiting for a fully remote (participants can fully participate from home) Clinical Trial to evaluate the Efficacy of Electrical Vestibular Stimulation (VeNS), for The Management of Anxiety.
Primary Outcomes: Reduced stress & anxiety
Locations: Belfast, Northern Ireland
Dates: 2022
Apply NowInsomnia
Insomnia is known to be one of the most common health concerns in the general population and has been associated with several health consequences. The Modius Sleep device is indicated to manage insomnia through the action of Cranial Electrotherapy Stimulation being delivered to the head in a non-invasive way that has been shown to be both safe and effective across multiple populations.
We are actively recruiting for a fully remote (participants can fully participate from home) Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Stimulation for the Management of Insomnia.
Primary Outcomes: Improved sleep & fatigue
Locations: Ulster University, Coleraine, Northern Ireland
Dates: 2022
Apply Now